Vesalius Longevity Labs was founded in Scottsdale, Arizona by Dr. Matt Cook, a pioneering regenerative medicine expert and founder of BioReset Medical, and Jennifer Benson, a board-certified integrative holistic health practitioner.
The company is building what it believes will be the first publicly traded platform dedicated exclusively to peptide and longevity therapeutics — distributed through a Business-to-Doctor (B2Doctor) model that requires every product to be prescribed by a licensed, credentialed healthcare provider.
Vesalius operates under current Good Manufacturing Practice (cGMP)-aligned sourcing standards, with third-party analytical testing on every lot and full chain-of-custody documentation. The company does not sell products directly to consumers.